Discontinued — last reported Q4 '25
Other Non-Current Assets
Non-Current AssetsEli Lilly Other Non-Current Assets increased by 8.7% to $6.99B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 22.2%, from $5.72B to $6.99B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 15.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ4 2008
Last reportedQ4 2025
How to read this metric
Significant changes may indicate shifts in long-term tax positions, restricted cash, or non-core strategic investments.
Detailed definition
A catch-all category for long-term economic resources that do not fit into primary classifications like PPE or Goodwill,...
Peer comparison
Varies widely by firm; usually represents a small percentage of total assets unless specific long-term prepayments or tax assets exist.
Metric ID:
other_non_current_assetsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.64B | $3.71B | $4.08B | $4.29B | $4.47B | $4.54B | $4.34B | $4.49B | $4.67B | $4.91B | $4.99B | $4.71B | $4.90B | $5.12B | $5.72B | $6.07B | $6.23B | $6.43B | $6.99B |
| QoQ Change | — | +2.0% | +10.0% | +5.0% | +4.3% | +1.4% | -4.4% | +3.5% | +4.1% | +5.1% | +1.6% | -5.6% | +4.2% | +4.4% | +11.7% | +6.2% | +2.5% | +3.3% | +8.7% |
| YoY Change | — | — | — | — | +22.9% | +22.2% | +6.2% | +4.7% | +4.5% | +8.3% | +15.1% | +4.9% | +5.0% | +4.3% | +14.6% | +29.0% | +26.9% | +25.6% | +22.2% |
Range$3.64B – $6.99B
CAGR+15.6%
Avg YoY Growth+14.4%
Median YoY Growth+14.6%
Current Streak7 quarters growth
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other non-current assets?
- Eli Lilly (LLY) reported other non-current assets of $6.99B in Q4 2025.
- How has Eli Lilly's other non-current assets changed year-over-year?
- Eli Lilly's other non-current assets increased by 22.2% year-over-year, from $5.72B to $6.99B.
- What is the long-term trend for Eli Lilly's other non-current assets?
- Over 5 years (2020 to 2025), Eli Lilly's other non-current assets has grown at a 15.0% compound annual growth rate (CAGR), from $3.48B to $6.99B.
- What does other non-current assets mean?
- Miscellaneous long-term assets that aren't categorized elsewhere.